[PCRX] YoY Annual Result on 31-Dec-2023 [#FY]

Stock
[PCRX] Pacira BioSciences, Inc.
Announcement Date
29-Feb-2024
Financial Year
2023
Quarter
31-Dec-2023 [#FY]
Profit Trend
YoY- 163.72%
Quarter Report
PCRX's Result
PCRX's Financial Summary
View:
Show?
Annual Result
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
Revenue 674,978 666,823 541,533 420,830 421,026 337,277 286,630 15.33%
PBT 61,701 13,302 56,404 20,089 -10,748 -425 -42,471 -
Tax 19,746 -2,607 14,424 -125,434 268 46 140 128.06%
NP 41,955 15,909 41,980 145,523 -11,016 -471 -42,611 -
Tax Rate -32.00% 19.60% -25.57% 624.39% - - - -
Total Cost 633,023 650,914 499,553 275,307 432,042 337,748 329,241 11.50%
Ratio Analysis
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
NP Margin 6.22 2.39 7.75 34.58 -2.62 -0.14 -14.87 -
Per Share
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
EPS 0.91 0.35 0.95 3.41 -0.27 -0.01 -1.07 -
EPS Diluted 0.81 0.34 0.92 3.33 -0.27 -0.01 -1.07 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.